ResearcherSichuan UniversityActive in the last 2 years
Hubing Shi
Matched on ORCID iD 0000-0002-2926-3440; OpenAlex author ID A5070267154. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 8
2023: 1 paper · 2024: none · 2025: 2 papers
Papers 3
- Single-cell transcriptional dissection illuminates an evolution of immunosuppressive microenvironment during pancreatic ductal adenocarcinoma metastasis. Last author DOI 10.1038/s41392-025-02265-0↗
- The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-24-1712↗
- Protocol for identifying immune checkpoint on circulating tumor cells of human pancreatic ductal adenocarcinoma by single-cell RNA sequencing. Last author DOI 10.1016/j.xpro.2023.102539↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiaowei Liu · 2 shared papers, 2023–2025 · strength 0.39
- Paper Single-cell transcriptional dissection illuminates an evolution of immunosuppressive microenvironment during pancreatic… DOI 10.1038/s41392-025-02265-0↗
- Paper Protocol for identifying immune checkpoint on circulating tumor cells of human pancreatic ductal adenocarcinoma by sing… DOI 10.1016/j.xpro.2023.102539↗
- Xuelei Ma · 2 shared papers, 2023–2025 · strength 0.39
- Paper Single-cell transcriptional dissection illuminates an evolution of immunosuppressive microenvironment during pancreatic… DOI 10.1038/s41392-025-02265-0↗
- Paper Protocol for identifying immune checkpoint on circulating tumor cells of human pancreatic ductal adenocarcinoma by sing… DOI 10.1016/j.xpro.2023.102539↗
- Wenyan Xie · 1 shared paper, 2025 · strength 0.20
- Jie Yang · 1 shared paper, 2025 · strength 0.20
- Hong Jiang · 1 shared paper, 2025 · strength 0.20
- Yunhua Liu · 1 shared paper, 2025 · strength 0.20
- Yuan Wang · 1 shared paper, 2025 · strength 0.20
- Nengwen Ke · 1 shared paper, 2025 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.